There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Healthequity (HQY – Research Report), Coya Therapeutics, Inc. (COYA – Research Report) and Iovance Biotherapeutics (IOVA – Research Report) with bullish sentiments.
Healthequity (HQY)
BTIG analyst David Larsen maintained a Buy rating on Healthequity today and set a price target of $110.00. The company’s shares closed last Tuesday at $83.53, close to its 52-week high of $84.13.
According to TipRanks.com, Larsen ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of
Currently, the analyst consensus on Healthequity is a Strong Buy with an average price target of $98.71, implying a 18.3% upside from current levels. In a report issued on March 15, Robert W. Baird also maintained a Buy rating on the stock with a $97.00 price target.
See the top stocks recommended by analysts >>
Coya Therapeutics, Inc. (COYA)
BTIG analyst Thomas Shrader maintained a Buy rating on Coya Therapeutics, Inc. yesterday and set a price target of $15.00. The company’s shares closed last Tuesday at $10.07, close to its 52-week high of $10.69.
According to TipRanks.com, Shrader is a 4-star analyst with an average return of
Currently, the analyst consensus on Coya Therapeutics, Inc. is a Moderate Buy with an average price target of $14.50, implying a 49.5% upside from current levels. In a report released today, Chardan Capital also reiterated a Buy rating on the stock with a $14.00 price target.
Iovance Biotherapeutics (IOVA)
In a report released yesterday, Yanan Zhu from Wells Fargo maintained a Buy rating on Iovance Biotherapeutics, with a price target of $25.00. The company’s shares closed last Tuesday at $13.90.
According to TipRanks.com, Zhu is a 5-star analyst with an average return of
Currently, the analyst consensus on Iovance Biotherapeutics is a Strong Buy with an average price target of $26.00, an 88.7% upside from current levels. In a report issued on March 4, H.C. Wainwright also reiterated a Buy rating on the stock with a $32.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on HQY:
